Companies Applying Genomics and Proteomics to Cancer

Author：

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.1, Iss.1, 2003-01, pp. : 60-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E. Liel Meghan S. Kohn Elise C.

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Technology: methodologies in genomics and proteomics

By Jon T. John M. Chris M.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Genomics and Proteomics of Nucleoside Transporters

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Applying proteomics to drug discovery

By Stubberfield C.R. Page M.J.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 1, 1999-01 ,pp. : 65-70

Informa Healthcare

Access to resources Recommend Favorite